Results 281 to 290 of about 8,750,628 (402)

Classification of Platelet‐Activating Anti‐Platelet Factor 4 Disorders

open access: yesInternational Journal of Laboratory Hematology, EarlyView.
ABSTRACT Introduction The prototypic anti‐platelet factor 4 (PF4) disorder—heparin‐induced thrombocytopenia and thrombosis (HITT)—features immunoglobulin G (IgG) class antibodies that activate platelets, monocytes, and neutrophils in a mainly heparin‐dependent fashion via Fcγ receptor‐dependent cellular activation.
Theodore E. Warkentin
wiley   +1 more source

Multiprofessional Family Care for Women With Gynaecological Cancer

open access: yesJournal of Advanced Nursing, EarlyView.
ABSTRACT Aim The aim of this study was to determine how family care is implemented in the care of women with gynaecological cancer from the perspective of health professionals in Finland. Design Multiphase convergent mixed‐methods research. Methods This study is based on two datasets collected from one Finnish university hospital. The first dataset was
Tea Metsävainio   +4 more
wiley   +1 more source

The Controversial Link Between Human Papillomavirus Infection and Esophageal Health: An Exploratory Translational Study. [PDF]

open access: yesPathogens
Egg M   +9 more
europepmc   +1 more source

Case-control study of human papillomavirus and oropharyngeal cancer.

open access: yesNew England Journal of Medicine, 2007
G. D’Souza   +7 more
semanticscholar   +1 more source

Achieving Cancer Prevention Equity: A Policy Analysis of American Cancer Society HPV Vaccination Guidelines

open access: yesJournal of Advanced Nursing, EarlyView.
ABSTRACT Aim To examine the American Cancer Society's HPV vaccination guidelines through a nursing policy analysis framework, assessing justice and equity outcomes in cancer prevention policy implementation. Background Human papillomavirus vaccination remains critical for cancer prevention, yet persistent health disparities undermine equity goals ...
Grace K. Kyei   +2 more
wiley   +1 more source

French guidelines on systemic treatments for moderate‐to‐severe psoriasis in adults: Update 2025

open access: yesJournal of the European Academy of Dermatology and Venereology, EarlyView.
New 2025 French guidelines update psoriasis management with revised algorithms integrating recent systemic therapies. They recommend methotrexate, adalimumab or ustekinumab as first‐line treatments and provide guidance for special psoriasis forms, comorbidities, pregnancy and long‐term management.
Marie Masson Regnault   +51 more
wiley   +1 more source

Home - About - Disclaimer - Privacy